Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The aging ovary.

S V Nicosia

    The Medical Clinics of North America
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Human ovarian aging involves continuous oocyte loss and structural changes, transforming the ovary from a cyclic hormone producer to a less active organ. Despite aging, the ovary remains viable post-menopause.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Editorial Expression of Concern: Deacetylation of cortactin by SIRT1 promotes cell migration.

    Oncogene·2024
    Same author

    Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation.

    Oncogene·2011
    Same author

    Deacetylation of cortactin by SIRT1 promotes cell migration.

    Oncogene·2008
    Same author

    Antiproliferative and apoptotic effect of ascorbyl stearate in human glioblastoma multiforme cells: modulation of insulin-like growth factor-I receptor (IGF-IR) expression.

    Journal of neuro-oncology·2002
    Same author

    Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.

    Cancer research·2001
    Same author

    AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells.

    The American journal of pathology·2001
    Same journal

    Care Transitions Continue to Evolve.

    The Medical clinics of North America·2026
    Same journal

    Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

    The Medical clinics of North America·2026
    Same journal

    Care Transitions and Value-Based Payment Models in the United States.

    The Medical clinics of North America·2026
    Same journal

    Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

    The Medical clinics of North America·2026
    Same journal

    Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

    The Medical clinics of North America·2026
    Same journal

    Social Determinants of Health: Unique Considerations in Transitions of Care.

    The Medical clinics of North America·2026
    See all related articles

    Area of Science:

    • Reproductive biology
    • Gerontology
    • Gynecology

    Background:

    • Ovarian aging is a lifelong process beginning before birth.
    • Oocyte attrition occurs through atresia, corpus luteum formation, and stromal cell transformation.

    Purpose of the Study:

    • To describe the structural and functional changes associated with human ovarian aging.
    • To understand the consequences of ovarian aging on hormonal secretion and ovarian activity.

    Main Methods:

    • Histological examination of ovarian tissue.
    • Analysis of cellular transformations and structural modifications.

    Main Results:

    • Ovarian aging leads to decreased follicles and altered hormonal output (estrogen, progesterone, androgen).

    Related Experiment Videos

  • Structural changes include arteriolar sclerosis and surface epithelium cysts.
  • The aged ovary exhibits both involution and persisting activity.
  • Conclusions:

    • Human ovarian aging is a dynamic process with significant structural and functional modulation.
    • The postmenopausal ovary retains viability, though its contribution to overall health requires further investigation.